Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Bullish Klaviyo Analyst Cites 3 Main Catalysts That Bode Well For Stock In 2024

Published 05/02/2024, 17:42
Updated 05/02/2024, 19:10
© Reuters.  Bullish Klaviyo Analyst Cites 3 Main Catalysts That Bode Well For Stock In 2024

Benzinga - by Priya Nigam, Benzinga Staff Writer.

Shares of Klaviyo Inc (NYSE: KVYO) climbed in premarket trading on Monday.

The stock’s 22% underperformance over the past three months offers “a buying opportunity,” especially with several catalysts for 2024 that could unlock equity value, according to Goldman Sachs.

The Klaviyo Analyst: Gabriela Borges upgraded the rating for Klaviyo from Neutral to Buy, while keeping the price target unchanged at $36.

Check out other analyst stock ratings.

The Klaviyo Thesis: Although the stock could remain volatile over the next 60 to 90 days, as there is greater clarity around the impact of email spam filtering on the company’s business, “we see a compelling path to stock outperformance over a 12-month time frame,” Borges said in the upgrade note.

The analyst cited three main catalysts for 2024:

  • The concerns around disruption to Klaviyo’s business model from the ongoing changes to email spam filtering appear to be overdone. “We look for more detail post the company’s 4Q EPS report on 2/27 and expect that solid 4Q results and additional information on these changes will help refute the near-term bear case on the stock,” she wrote.
  • Klaviyo could continue to gain market share, given its “differentiated approach to the software infrastructure underpinning its marketing application,” Borges stated.
  • These is upside to estimates even considering “any near-term downsizing of customer contracts given company-specific drivers (upmarket gains, ongoing Shopify Plus penetration, new products) and an overall still-stable consumer spending environment,” she added.
KVYO Price Action: Shares of Klaviyo rose by 4.8% to $29.01 in premarket trading on Monday.

Image: Pixabay

© 2024 Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.